BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$291.88 USD
-1.97 (-0.67%)
Updated May 20, 2024 04:00 PM ET
After-Market: $291.76 -0.12 (-0.04%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 2.10 |
EPS Last Quarter | 2.29 |
Last EPS Surprise | 12.25% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 10.42 |
Next Year | 11.46 |
EPS (TTM) | 10.72 |
P/E (F1) | 28.21 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 646.64M | 683.77M | 2.68B | 2.84B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 648.18M | 683.93M | 2.68B | 2.84B |
Low Estimate | 645.10M | 683.60M | 2.68B | 2.84B |
Year ago Sales | 681.11M | 632.12M | 2.67B | 2.68B |
Year over Year Growth Est. | -5.06% | 8.17% | 0.26% | 6.02% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.10 | 2.80 | 10.42 | 11.46 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | 2.17 | NA | 10.43 | 11.47 |
High Estimate | 2.17 | 2.80 | 10.43 | 11.47 |
Low Estimate | 2.03 | 2.79 | 10.40 | 11.45 |
Year ago EPS | 3.00 | 2.33 | 11.78 | 10.42 |
Year over Year Growth Est. | -30.00% | 20.17% | -11.54% | 10.03% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.10 | 2.80 | 10.42 | 11.46 |
7 Days Ago | 2.10 | 2.80 | 10.42 | 11.46 |
30 Days Ago | 2.10 | 2.80 | 10.42 | 11.46 |
60 Days Ago | 2.34 | 2.80 | 10.58 | 11.98 |
90 Days Ago | 2.85 | 2.81 | 11.38 | 14.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.10 | 2.80 | 10.42 | 11.46 |
Zacks Consensus Estimate | 2.10 | 2.80 | 10.42 | 11.46 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.29 | 3.10 | 2.33 | 3.00 | NA |
Estimate | 2.04 | 2.93 | 2.87 | 2.55 | NA |
Difference | 0.25 | 0.17 | -0.54 | 0.45 | 0.08 |
Surprise | 12.25% | 5.80% | -18.82% | 17.65% | 4.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more